(6-166) Efficacy and Safety of Reduced Apixaban and Rivaroxaban Oral Lead-In Dosing After Receipt of Parenteral Anticoagulation: A Literature Review

Tuesday, December 9, 2025

10:45 AM - 11:45 AM

Location: Bayside A, Level 1

Pharmacy School: University of Oklahoma Health Sciences Center College of Pharmacy
Pharmacy School Location: Oklahoma

Co-Author(s): Corey Guidry

Primary Author(s)

Jordan Rahilly, n/a

Pharmacy Student/Intern
University of Oklahoma College of Pharmacy